Voluntary recall addresses Vecuronium Bromide

Published on: Thursday, April 15, 2021

Teva Pharmaceuticals USA has issued a voluntary recall for specified lots of injectable Vecuronium Bromide to address a potential lack of sterility assurance. The lots addressed in the recall notice are as follows:

• 31325712B, expiration date 12/2021
• 31326320B, expiration date 02/2022
• 31326457B, expiration date 02/2022
• 31327880B, expiration date 10/2022

If your institution has stock from any of the affected lots, please contact your supplier for additional instructions regarding product returns.